Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomivir in Relieving Influenza Symptoms
NCT01677689Phase 2Not yet recruiting
- Sponsor
- Far East Bio-Tec Co., Ltd.
- Start
- May 2026
- Primary completion
- May 2027
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Apomivir in influenza, sponsored by Far East Bio-Tec Co., Ltd.. Planned start May 2026; status: not yet recruiting.
02
Drugs
Apomivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01677689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01677689.